![Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22801-0/MediaObjects/41467_2021_22801_Fig1_HTML.png)
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications
![Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3eb8aeb3ef0e5fbd41ccaac4c356ef547e9dadef/22-Table2-1.png)
Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar
![PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer](https://www.researchgate.net/profile/Joachim-Pawel/publication/242354126/figure/tbl2/AS:393144983146497@1470744476106/Recommendations-for-use-of-markers-according-to-histologies-of-lung-cancer-and_Q320.jpg)
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
![Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/1305934/f/1.png)
Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![Cancers | Free Full-Text | Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA) Cancers | Free Full-Text | Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA)](https://pub.mdpi-res.com/cancers/cancers-12-00037/article_deploy/html/images/cancers-12-00037-g001.png?1581004272)
Cancers | Free Full-Text | Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA)
![Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research](http://www.cjcrcn.org/data/pic/3347_0.png)
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
TINY Notes - 記marker很易忘,但大原則是: 1. 不應一股腦兒全部都染,成本太高,也影響解讀。如果臨床H&P詳細,病理也不會太辛苦。 2. 不同的tumor可能會表現不同種的tumor marker,像是同樣是lung cancer,adenoma和small cell lung CA的表現就不同
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE
![A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer - eBioMedicine A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer - eBioMedicine](https://www.thelancet.com/cms/asset/7cee8ea5-7859-42fa-9c45-9b933c1c7409/gr1.jpg)